Defining the clinical relevance of red blood cell autoantibodies by Monocyte Monolayer Assay.

@article{Conrado2018DefiningTC,
  title={Defining the clinical relevance of red blood cell autoantibodies by Monocyte Monolayer Assay.},
  author={Marina Cavalcanti Albuquerque Veiga Conrado and Amanda N D'Avila and Juliana B Vieira and Silvia L Bonif{\'a}cio and Francisco Carlos Almeida Gomes and Marcia Regina Dezan and Valeria Brito Oliveira and Ingrid Helena Ribeiro and Luciana Tomanik Cardozo de Melo Tucunduva and Alfredo Mendrone-Junior and Vanderson Geraldo Rocha and Carla Luana Dinardo},
  journal={Journal of clinical laboratory analysis},
  year={2018},
  volume={32 2}
}
BACKGROUND The Monocyte Monolayer Assay (MMA) is an in vitro simulation of red blood cell (RBC) alloantibody behavior. It has been classically applied to predict the risks of post-transfusion hemolytic reactions when transfusing incompatible RBC units. Quantifying erythrophagocytosis by MMA may be an interesting option for situations where there is doubt… CONTINUE READING